Abstract. We describe the concept and methods of peptide ligation and tandem peptide ligation for preparing synthetic and natural biologicals. Peptide ligation is a segment coupling method for free peptides or proteins through an amide bond without the use of a coupling reagent or a protecting group scheme. Because unprotected peptides or proteins prepared from either a chemical or biochemical source are being used as building blocks, the ligation removes the size limitation for peptide and protein synthesis. A key feature of the peptide ligation is that the coupling reaction is orthogonal, i.e. it is specific to a particular -amino terminus (NT). This NT-amino acid-specific feature permits the development of a tandem peptide ligation method employing three unprotected peptide segments containing different NT-amino acids to form consecutively two amide bonds, an Xaa-SPro (thiaproline) and then an Xaa-Cys. This strategy was tested in peptides ranging from 28 to 70 amino acid residues, including analogues of somatostatins and two CC-chemokines MIP-1 and MIP-1 . The thiaproline replacements in these peptides and proteins did not result in altered biological activity. By eliminating the protecting group scheme and coupling reagents, tandem ligation of multiple free peptide segments in aqueous solutions enhances the scope of protein synthesis and may provide a useful approach for preparing protein biologicals and synthetic vaccines.
Introduction
Over the last decade, a significant methodological development known as peptide ligation has been described for the chemical synthesis of peptides and proteins. [1] [2] [3] Peptide ligation enables the coupling of free peptides or proteins through an amide bond ( Fig. 1) . Moreover, this ligation is specific or orthogonal to a particular NT amino acid of an unprotected peptide or protein. Such an NT-amino acid-specific amide-bond ligation method is remarkable, considering that there are two or more NT-amines, side-chain amines and other nucelophiles present in the free peptides and proteins and yet only one specific amide bond is being formed. In this regard, peptide ligation contains attributes of an enzymatic synthesis but without the aid of an enzyme.
Peptide ligation is conceptually di#erent from the conventional chemical methods; it is based on the use of protecting groups, coupling reagents and reactions performed in organic solvents. First, peptide ligation uses free peptides and their esters as building blocks without a protecting group scheme. Conventional chemical methods generally require the use of a protecting group scheme and cannot use unprotected peptides or proteins that are prepared from the recombinant source. The ability of this method to use biosynthetic building blocks removes the size limitation of peptides or proteins that can be prepared by peptide ligation because the recombinant DNA methods can generate proteins of any size. Peptide ligation also has an advantage over the recombinant methods because, as a chemical method, it can prepare proteins containing unusual amino acids, structures and architectures.
Second, peptide ligation is performed without a coupling reagent to produce an amide bond *To whom all correspondence should be addressed. Tel:
1-615-343-1465; Fax: 1-615-343-1467; E-mail: tamjp@ctrvax.vanderbilt.edu formation. Furthermore, this ligation is usually performed in aqueous conditions. Consequently, successful applications of this ligation method have been demonstrated in semi-and total synthesis of peptides, glycopeptides, proteins and dendrimers as well as modifications of living systems such as cell surfaces and phage-display libraries.
Finally, the products usually do not need a deprotecting step after the ligation reaction and, in some cases, can be used directly for biological assays. Peptide ligation is also di#erent from the chemo-selective ligation of unprotected peptides or site-specific conjugation methods known in protein chemistry (Table 1) . These methods generally yield non-amide bonds such as thioethers, oximes and hydrazones at the ligation sites.
The mechanism of peptide ligation mimics certain aspects of some proteolytic enzymes such as NT-hydrolase and inteins found in protein splicing 4 that are characterized by a series of acyl transfer reactions. Generally, peptide ligation consists of a two-step reaction: a variable capture step of a mutually reactive pair of a nucleophile and an electrophile to form an ester or thioester, and then an invariable O,N-or S,N-acyl transfer step to form an amide bond. Because this invariable acyl transfer step is proximity-driven and spontaneous, it eliminates the need for a coupling reagent and a protecting group scheme. However, the variable capture step forming an ester intermediate is the key step in providing the chemo-selectivity of the peptide ligation and has become the focus of our research.
Two major approaches to chemo-selective captures have been developed, imine capture to form a pseudoproline (Xaa-SPro/OPro) bond and thioester capture to form a Cys (Xaa-Cys) bond. Thiaproline (SPro) ligation 5 is the first example that demonstrates the principle of orthogonal peptide ligation by coupling an NT-Cys segment 2 and a CT-ester glycoaldehyde 1 to form an Xaa-SPro at the ligation site (Fig. 2) . The capture between an NT-Cys segment 2 and a CT-glycoaldehyde ester 1 to form a thiazolidine ester is fast and specific. Using a library of 400 dipeptides containing all 20 NT-amino acids, the thiazolidine ligation of NT-Cys is >1000 fold faster than NT-Thr and NT-Trp under aqueous conditions. NT-Ser and NT-Asn are essentially unreactive in 72 h. This high reactivity between the CT-aldehyde 1 and the NT-Cys 2 under aqueous conditions illustrates the selectivity in the orthogonality concept of the peptide ligation. Recently, oxaproline (OPro) ligation with NT-Ser or NT-Thr has also been developed using a non-aqueous solvent system The imine capture is performed in acidic conditions to avoid side reactions of aldehyde with other nucleophiles present in peptides. This feature makes the imine capture reaction very useful for the purpose of chemoselective ligation of two molecules, even without the acyl transfer reaction, and can be applied to regiospecific conjugation reactions in protein chemistry. The ring-chain isomerization favours the ring closure to form a heterocyclic ring 3, either as a thiazolidine from NT-Cys or as an oxazolidine from NT-Ser or NT-Thr. The secondary amine in the thiazolidine 4 acts as a weak base and can undergo an O,N-acyl migration through a favourable five-membered ring transition state at pH 5 to form at the ligation site a proline mimic, 2-hydroxymethyl thiaproline 5. While the ring formation is fast, the rearrangement is generally slow and constitutes the rate-determining step of the ligation. The rate of rearrangement increases with the increased pH and depends on the steric and electronic environment of the amino and carboxyl components. Small amino acids such as Gly and Ala are the preferred choices.
The second approach for chemo-selective capture is through a thiol-thioester exchange reaction in the cysteine ligation. 1, 7, 8 It involves a CT-thioester 6 and an NT-nucleophile Cys 7 and regenerates Cys at the ligation site (Fig. 3) . Cys ligation possesses two ideal elements in the orthogonal ligation strategy. First, Cys bearing a thiol supernucleophile as an NT-nucleophile readily undergoes a thiol-thioester exchange reaction with a CT-electrophile thioester 6 that, after the acyl migration, regenerates the thiol moiety on the NT-nucleophile amino acid. This preserves the integrity of the side-chain functional group of the NT-nucleophile amino acid at the ligation site. Second, the thioester as a CT-electrophile contains perhaps the most favourable spatial arrangement of these two functional groups, with the alkyl thiolate electrophile directly linked to the acylating carbonyl. Such an arrangement provides not only an activated ester but also a highly desirable five-member ring intermediate 8 for an intramolecular acyl migration after the thioester capture. Consequently, Cys ligation by thioester capture has been extensively exploited in chemical and, more recently, semi-synthesis of proteins.
Several conditions for ligating CT-thioester with NT-cysteine peptide have been reported. Most ligations are performed under aqueous conditions bu#ered at pH 7-8 by sodium phosphate. A critical condition necessary for Cys ligation is the maintenance of a reducing environment to prevent N, S-bisacylated byproduct and reduce disulphide formation. A combination of R 3 P and a large excess of an alkyl thiol improved the yield from 75% to >95% in a model peptide and was considered an optimal condition for thiol-thioester exchange. Tris(2-carbonylethyl)phosphine (TCEP) is convenient to use because it is water-soluble and rapidly reduces the blocked disulphide forms of the NT-Cys segments to their reactive forms. A large excess of a small thiol such as 3-mercaptopropionic acid (MPA) or 2-mercaptoethanesulfonate is added to regenerate the NT-Cys nucleophile and free cysteine from the bisacylated byproduct.
The regiospecificity of Cys ligation is exceptionally high in aqueous bu#er between pH 7 to 8. At this pH range, the selectivity of a thiol over amines is substantial because the thiol group is a stronger nucleophile. As a result, there are no significant side reactions in the peptides containing side-chain functionalities such as the amine of lysine, thiol of cysteine, guanidine of arginine and imidazole of His at internal positions of the peptide sequence. Several methods for the Xaa-Cys bond formation, including the use of a CT-thiocarboxylic acid with an NT-Cys to form a covalent perthioester, have also been reported.
Here, we describe a tandem ligation strategy of three unprotected peptide segments by employing imine and thioester captures of NT-Cys peptides toward two CT-electrophiles to form an Xaa-SPro (thiaproline) and an Xaa-Cys bond at the ligation sites. Since thiaproline is a proline surrogate, we show here that the biological activity is not altered by the proline<thiaproline substitutions in these bioactive peptides and proteins.
Material and methods

Materials
Analytical RP-HPLC was performed on a Shimadzu system with a Vydac column (0·46 cm 25 cm, C 18 ) at a flow rate of 1 ml/min with a linear gradient of 10% to 100% bu#er B (60% acetonitrile in H 2 O/0·04% TFA) in bu#er A (5% acetonitrile in H 2 O/0·045% TFA) over 30 min. E#luent was monitored with UV at 225 nm. A preparative HPLC equipment (Waters Associates) with a Vydac C 18 reverse phase column was used for peptide purification. Mass spectra were obtained from a Kratos mass spectrometry instrument with positive matrix-assisted laser desorption ionization mode (MALDI-MS).
Peptide ester glycoaldehyde 9
Fmoc peptide-OCH 2 -cyclic acetal resin was prepared according to the procedure described. After cleavage using 95% TFA, the crude peptide-glyceric ester was dissolved in a phosphate bu#er (0·2 M, pH 6·2). To this solution, NaIO 4 solution in the same bu#er (0·5 mmol/ml) was added. After 30 min, the peptide aldehyde was purified by HPLC. Typically, AK37-CHO was prepared from AK37-(OH) 2 (1 mg in 200 l bu#er, 0·2 mol) and 20 l NaIO 4 solution (1 mol) in a yield of 72% (yield was based on area ratio of corresponding HPLC peaks, MH calcd. 4326·9 found 4327·5).
Thioester resins [10] [11] Thioester resins were prepared with a modified Hojo and Aimono's procedure. Four equivalents each of 3-mercaptopropionic acid, HOBt, and DIC were sequentially added to a suspension of 4-methylbenzhydrylamine (MBHA) resin in DMF (10 ml/g resin). The mixture was shaken at room temperature until a ninhydrin test of the resin indicated that no free amino sites were present. The resin was washed with DMF, DCM, CH 3 OH, DCM and DMF. The resulting resin was treated with a mixture of one equivalent each of cysteine methyl ester hydrochloride, triphenylphosphine, and DIEA in DMF/DCM (3:1, v/v) for two hours. After thorough washing with DMF, DCM, CH 3 OH, and DCM and drying in vacuo, the mercaptopropionyl MBHA resin was obtained in quantitative yield (6·3 g from 6·0 g MBHA resin).
Boc-amino acid (4 equiv.) preactivated with BOP (4 equiv.) and DIEA (6 equiv.) in DMF for five minutes was added to a suspension of mercaptopropionyl MBHA resin (1 equiv.) in DMF (10 ml/g resin). The mixture was shaken at room temperature for 2 h and free thiol groups were monitored by Ellman's reagent. The resin was washed with DMF, DCM, CH 3 OH and DCM and used for stepwise peptide synthesis.
Synthesis of peptide thioesters
All thioesters were prepared by solid phase synthesis starting from Boc amino acid thioester resin 12 using conventional Boc-chemistry and DCC-HOBt coupling protocol. After peptide chain elongation, the peptides were released from the resin with high HF procedure (90% HF), purified by preparative HPLC and characterized by MALDI-MS.
Imine ligation between N-and M-segment
Typically, to the solution of 0·1 mol N-segment dissolved in 200 l 0·2 M acetate bu#er (pH 3·0), 1·1 equiv. of M-segment was added. The ligation mixture was kept at room temperature overnight. The ligation product was then purified by HPLC giving a yield of 70-90%. For MIP-1 and MIP-1 , one third volume of acetonitrile was added to increase the solubility and give better results.
Thioester ligation between NM-and C-segments
To the solution of NM-segment (0·1 mol) in 100 l 0·2 M phosphate bu#er (pH 7·2) containing three equiv. TCEP, 1·1 equiv. of C-segment was added. After three hours at room temperature, 1 l of MPA was added and the reaction mixture was agitated for 40 minutes. The ligation product was then purified by HPLC and lyophilized to dryness. For MIP-1 and MIP-1 , 0·1 mol of NM-segments and 1·2 equiv. of C-segments were dissolved in 200 l of 8 M guanidine HCl/0·2 M phosphate bu#er (50:50, v/v) pH 7·6. Thiophenol (1% by volume) was added and the ligation mixture shaken overnight (18-24 h). Water (400 l) was then added and the reaction mixture extracted with 3 200 l of ether to remove the thiophenol. The aqueous phase was evaporated under vacuum to remove ether. The solution was then applied to HPLC to give the desired ligation products.
Results and discussion
Tandem peptide ligation 13, 14 Previously, we have shown that inter-and intramolecular thioester-cysteine ligations are best performed at basic conditions (pH >7) whereas SPro-imine ligation is better in acidic conditions at pH <5. Under acidic conditions, the thiol-thioester exchange between an NT-Cys and the CT-thioester is slow while the imine capture between an aldehyde and an NT-Cys is fast. This di#erential reactivity of an NT-Cys peptide under acidic and basic conditions toward two di#erent CT-esters provides the basis for the three-segment ligation involving two NT-Cys to form two amide bonds in tandem.
The three-segment tandem ligation strategy was performed in the N<C direction (Fig. 4) on three unprotected segments to form first an Xaa-SPro (thiaproline as an Xaa-Pro bond surrogate) and then an Xaa-Cys bond. For convenience, these three segments were also designated in the N<C direction as the amine segment (N-segment) 10 containing a C-terminal glycoaldehyde ester, the middle segment (M-segment) 11 containing both a CT-thioester and an NT-cysteine, and the carboxyl segment (C-segment) 13 also containing an NT-cysteine.
SPro ligation of the N-segment 10 and M-segments 11 proceeds through an imine capture of the CT-glycoaldehyde ester. A thiazolidine ester intermediate is formed and then an O,N-acyl transfer takes place to form a C2-hydroxymethyl thiaproline at the ligation site through a favourable five-member ring intermediate (Fig. 2) . Recently, we have confirmed that the SPro ligation with an NT-Cys (-configuration) segment is stereospecific and a#ords an R-epimer at the newly created stereocentre at the C2 carbon of the SPro at the ligation site. Intermolecular Cys-thioester ligation of the NM-segment 12 containing a CT-thioester with the C-segment 13 containing an NT-Cys proceeds through a covalent and branched thioester undergoes a spontaneous S,N-acyl migration through a five-membered ring to form an Xaa-Cys bond in the final product 15. However, the intramolecular thioester ligation of a peptide such as the M-segment 11 containing both an NT-Cys and a CT-thioester is equally facile and has been extensively exploited for preparing cyclic peptides. Thus, the inter-and intramolecular ligation of the M-segment poses a challenge in our synthetic scheme.
Previously, we have shown that inter-and intramolecular thioester-cysteine ligations are best performed at basic conditions (pH >7) whereas SPro ligation is better under acidic conditions at pH <5. In acidic conditions, the thiol-thioester exchange between an NT-Cys and the CT-thioester is slow while the imine capture between an aldehyde and an NT-Cys is fast. This di#erential reactivity of an NT-Cys peptide under acidic and basic conditions toward two di#erent CT-esters provides the basis for the three-segment ligation involving two NT-Cys to form two amide bonds in tandem.
Tandem ligation using the diester intermediate
Based upon the above rationale, a standardized condition was used for the thiaproline-thioester ligation in tandem (Fig. 4) . (1) The first SPro ligation of N-and M-segments (10 and 11) was performed at pH 3. Under such conditions, the protonated nature of the NT-cysteinyl thiol inhibits thioester ligation but permits imine capture of the CT-glycoaldehyde ester and its tautomerization to a stable thiazolidine ester. At pH 3, the O,N-acyl migration to form an Xaa-SPro bond is slow and incomplete, but can be accomplished during steps 2 and 3 when they are performed at pH 7-8. (2) The second step is the Cys-thioester ligation of NM-and C-segments that produces NMC-branch esters. It can proceed, after adjusting the pH to >7·2 with solid NaHCO 3 , either directly by adding a C-segment to the reaction mixture (one-pot reaction) or to the purified NM-segment.
Synthesis of somatostatin-28, MIP-1 and MIP-1
Sm-28. Somatostatin-28 (Sm-28) contains 28 amino acid residues and is widely distributed in central nervous system and digestive tract tissues.
[SPro10]Sm-28 with a thiaproline<Pro10 replacement was prepared by three-segment tandem ligation to validate its application for a mediumlength peptide containing disulphides (Fig. 5) . The ligation sites were based on the occurrence of Pro and Cys, respectively, at positions 10 and 17 of the Sm-28 sequence.
Sm-28 was also selected because it contains an NT-Ser that presents a potential synthetic problem because it is susceptible to oxidization during the NaIO 4 conversion of the CT-glyceric to its glycoaldehyde ester for imine ligation. At pH 7, oxidation of NT-Ser to an -oxo moiety was 1000-fold faster than the CT-1,2-diol. At pH <6, our model compound showed a reverse selectivity of diol over the 1,2-amino alcohol of NT-Ser oxidation with NaIO 4 . Selectivity increased with an increase in acidity, which can probably be attributed to the increased protonated states of the NT-Ser. At pH 3, the CT-glyceryl ester was completely oxidized to aldehyde within three min without significant oxidation of NT-Ser. Thus, for N-segments containing NT-Ser and NT-Thr, selective conversion of CT-glyceryl ester to its corresponding aldehyde can be achieved at acidic pH. Under this condition, the methionine residue in the N-segment SA-9 was oxidized to Met(O). To avoid the Met oxidation, we fine-tuned the oxidation condition and found that the optimal pH was around pH 6. At pH 6·2, treatment of the N-segment SA9-glycerylester with five equivalents of NaIO 4 in 0·5 h a#orded the desired CT-aldehyde with 80% yield without a#ecting Met. Longer oxidation time produced a significant amount of Met(O) and an -oxo side product from NT-Ser oxidation.
MIP-1 and MIP-1 . MIP-1 and MIP-1 are members of the CC-chemokine proteins of 8-10 KDa. 15 These chemokines are primarily involved in the chemoattractant potential of monocytes and lymphocytes and have been implicated in a variety of clinically important inflammatory diseases, and more recently as inhibitors of HIV pathogenesis. Structurally, these two chemokines display significant sequence homology that permits comparison of ligation sites at di#erent Pro and Cys residues to test the conformational influence of the tandem ligation reactions. A synthetic challenge is the presence of two adjacent Cys at the N-terminal segments, a sequence motif of CC-chemokines that require manipulations to avoid side reactions during the oxidative transformation to the CTglycoaldehyde ester for the SPro ligation between the N-and M-segments.
The 70-residue MIP-1 contains Pro at positions 21 and 38, and either of which is a suitable choice as an imine ligation site to a#ord a SPro<Pro analogue. Ligation at Pro38 would require an N-segment with a CT-Lys37-glycoaldehyde ester. The participation of this CT-lysyl side-chain amine through either intramolecular lactam or Schi# base formation may interfere in the imine capture during the SPro ligation. To resolve this potential side reaction, we selected Lys37-Pro38 as the imine ligation site and Cys52 for the thioester ligation. Thus, three segments of 37, 13, and 20 residues corresponding to the N-, M-and C-segments with the N-segment being the longest of the three, were prepared for the tandem ligation via thiaproline (37+13 amino acid-segments) and thioester (50+ 20 amino acid-segments) for the synthesis of [SPro38]MIP-1 .
The 69-residue MIP-1 also contains Pro at positions 21 and 38. To prepare [SPro21]MIP-1 , Pro21 and Cys35 were selected as ligation sites and required the syntheses of three segments containing 20, 14 and 35 amino acid residues of which the C-segment was the longest. While the Cys-thioester ligation of MIP-1 consisted of two segments of 50 and 20 residues, the NM-and C-segments, ligated in MIP-1 were roughly equal, containing 34 and 35 residues, respectively.
Imine capture between N-and M-segments and thioester ligation between NM-and C-segments proceeded smoothly under the conditions previously described (see the Materials and methods). In the presence of excess thioester, the free cysteinyl thiol produced under the ligation condition can react again with the NM-segment thioester yielding an N,S-diacyl by-product. To limit the formation of this diacyl byproduct, a slight excess of C-segment was used. After ligation, a small thiol MPA was added to the reaction mixture to regenerate product from the N,S-diacyl by-product.
After completing the tandem ligation, the crude product was treated with 20% DMSO in an aqueous solvent bu#ered at pH 6·2 for 24 h for the disulphide formation. As discussed previously, the O,N-acyl migration of the thiazolidine ester at the N-to-Msegment ligation site was slow and therefore the period for disulphide oxidation was prolonged to permit completion of the O,N-acyl migration. Progress of the ligation reaction as monitored by HPLC showed that the thiaproline bond was indeed complete after the DMSO oxidation. Treatment with 1 M NH 2 OH at pH 9·0 for one hour further confirmed that the thiaproline ligation site was an amide bond because the thiazolidine ester bond was susceptible to base treatment and would yield two segments.
Biological activity
The biological activities of three ligation products, [SPro10]somatostatin, [SPro38]MIP-1 and [SPro21]MIP-1 , were compared with their native products by radio-receptor binding assay and chemotaxis assay, respectively. Dose-dependent response of radio-receptor assays showed that the activity of the native somatostatin-28 and [SPro10]somatostatin were indistinguishable and both completely inhibited specific receptor binding in mouse AtT-20 cells expressing somatostatin receptors at about 10 nM. The migration capacity of [SPro38]MIP-1 and [SPro21]MIP-1 counter was compared with the native MIP-1 and MIP-1 on P4-CCR5 cells using a chemotactic assays. All four compounds showed dose-dependent responses at concentrations of 0·01 to 1000 ng/ml to P4-CCR5 cells with a maximal response at 1 ng/ml. The chemotactic indexes of MIP-1 and MIP-1 at 1 ng/ ml were 3·9 and 2·7, respectively. At the same concentration, the chemotactic indices of [SPro38]MIP-1 and [SPro21]MIP-1 were 3·1 and 2·3 ng/ml, respectively. There was no significant di#erence (P<0·05) between the thiaproline and native MIP-1 or MIP-1 chemokines.
